{"a":[{"_":"White House unveils next round of MFN pricing deals with 9 midsized drugmakers","$":{"href":"/pharma/white-house-unveils-next-round-mfn-pricing-deals-9-midsized-drugmakers","hreflang":"en"}}]}

Summary

The White House announced a second round of drug pricing agreements under President Trump's most-favored-nation (MFN) pricing agenda, this time with 9 medium-sized biopharmas, following similar deals completed with 17 major drugmakers four months prior.